Search - tctmd.com

Displaying 241 - 260 of 1551

Sort: Relevancy | Date

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

L.A. McKeown

September 20, 2022

Presentation TCT 2022

TCT 113: Predicting the Risk of In-hospital Major Adverse Cardiovascular Events in Chronic Total Occlusion Percutaneous Coronary Intervention: The PROGRESS-CTO MACE Score

Presenter: Bahadir Simsek

September 17, 2022

News Daily News

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

Yael L. Maxwell

September 14, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

Todd Neale

August 27, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

Yael L. Maxwell

August 16, 2022

News Daily News

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

Yael L. Maxwell

August 03, 2022

News Daily News

AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death

Caitlin E. Cox

July 22, 2022

News Industry News

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

July 20, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

Lower 10-Year Mortality With Multiple Arterial CABG in Diabetes: ART

Yael L. Maxwell

June 28, 2022

News Daily News

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

Yael L. Maxwell

June 24, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for June Week 4

Todd Neale

June 20, 2022

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

News Conference News EuroPCR 2022

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

Yael L. Maxwell

May 24, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

Presentation EuroPCR 2022

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Presenter: Felix Mahfoud

May 20, 2022

Advertisement

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

TCT 113: Predicting the Risk of In-hospital Major Adverse Cardiovascular Events in Chronic Total Occlusion Percutaneous Coronary Intervention: The PROGRESS-CTO MACE Score

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

High Lp(a) May Predict Risk of CV and Limb Events in PAD

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Lower 10-Year Mortality With Multiple Arterial CABG in Diabetes: ART

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

COVID-19: TCTMD’s Dispatch for June Week 4

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content